跳至主要内容
临床试验/NCT07383480
NCT07383480已完成不适用

Enhancing Embryo Selection With AiVF: A Major Advancement in ART - A Retrospective Study

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 333 人开始时间: 2022年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
333
试验地点
1
主要终点
Comparison of artificial intelligence (AI) Score and Laboratory Embryo Classification

研究概览

简要总结

In assisted reproductive technology (ART), selecting the most viable embryos from a large number of fertilized eggs is crucial. While techniques like morphological assessment, time-lapse monitoring systems, and pre-implantation genetic testing have improved the process, implantation success rates remain limited. The introduction of artificial intelligence in embryo evaluation, such as automated systems like EMA by AIVFTM, provides a promising alternative to enhance the accuracy and effectiveness of embryo selection. This study aims to assess the performance of the EMA system compared to traditional methods by examining its ability to rank embryos based on their potential for successful implantation, with the goal of increasing the chances of a successful pregnancy. This is the first clinical evaluation of this platform in France, offering new opportunities to improve decision-making in in-vitro fertilization.

详细描述

This monocentric study analyzes 420 ART cycles from the Clermont-Ferrand University Hospital, conducted between January 2022 and December 2023. It includes IVF/ICSI cycles with embryos cultured in a Time-Lapse Incubator (Geri) and both fresh and frozen blastocyst transfers. A total of 1211 embryos were analyzed, with 619 used to train algorithms for predicting reproductive outcomes. This included 551 single and 34 double embryo transfer cycles, divided into 274 fresh and 345 frozen blastocyst transfers. For all blastocyst-stage embryos, the Geri score, Gardner classification, and EMA score based on time-lapse video were recorded for statistical analysis and evaluation of reproductive outcome predictions

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • IVF or ICSI treatment between January 2022 and December 2023
  • Fresh or frozen sperm from the partner or a donor
  • Embryo culture up to the 105th hour
  • Fresh or frozen embryo transfer on Day 5
  • Known implantation data (clinical pregnancy assessed by the presence of cardiac activity at 6 weeks via ultrasound)

排除标准

  • Epididymal or testicular sperm
  • Embryo culture with transfer on Day 2 or Day 3
  • ICSI with oocyte donation or the use of thawed oocytes
  • Transfer of two embryos resulting in a singleton pregnancy
  • No blastocyst obtained on Day 5

结局指标

主要结局

Comparison of artificial intelligence (AI) Score and Laboratory Embryo Classification

时间窗: 01/01/2022-31/12/2023

The study aims to compare the EMA score assigned by the EMA platform (AiVFTM), an artificial intelligence-based tool, with the manual embryo classification performed by embryologists in the laboratory. This manual classification includes morphological assessment using the Gardner grading system and morphokinetic evaluation through the GERI score. The goal is to determine the level of concordance between the AI-generated scores and traditional embryologist assessments, and to evaluate the relationship and possible variability between the EMA score and the manual scoring methods.

次要结局

  • To determine the association between EMA Score and implantation and live birth rates(01/01/2022-31/12/2023)
  • To evaluate the optimal EMA score threshold for maximizing live birth rates(01/01/2022-31/12/2023)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验